Health-Related Quality of Life Outcomes in Patients With Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept in the MEDALIST Study

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 01期
关键词：
TRANSFUSION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [1] Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the Medalist Study
    Oliva, Esther Natalie
    Platzbecker, Uwe
    Garcia-Manero, Guillermo
    Mufti, Ghulam J.
    Santini, Valeria
    Sekeres, Mikkael A.
    Komrokji, Rami S.
    Shetty, Jeevan K.
    Tang, Derek
    Guo, Shien
    Liao, Weiqin
    Zhang, George
    Ha, Xianwei
    Ito, Rodrigo
    Lord-Bessen, Jennifer
    Backstrom, Jay T.
    Fenaux, Pierre
    [J]. BLOOD, 2020, 136
  • [2] Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial
    Oliva, Esther Natalie
    Platzbecker, Uwe
    Garcia-Manero, Guillermo
    Mufti, Ghulam J.
    Santini, Valeria
    Sekeres, Mikkael A.
    Komrokji, Rami S.
    Shetty, Jeevan K.
    Tang, Derek
    Guo, Shien
    Liao, Weiqin
    Zhang, George
    Ha, Xianwei
    Ito, Rodrigo
    Lord-Bessen, Jennifer
    Backstrom, Jay T.
    Fenaux, Pierre
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [3] Effects of Luspatercept on Serum Ferritin in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts in the Phase 3 MEDALIST Trial
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 17 - 18
  • [4] DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Stojkov, Igor
    Conrads-Frank, Annette
    Rochau, Ursula
    Arvandi, Marjan
    Koinig, Karin
    Schomaker, Michael
    Puntscher, Sibylle
    Schmid, Daniela
    van Marrewijk, Corine
    Smith, Alexandra
    de Witte, Theo
    Stauder, Reinhard
    Siebert, Uwe
    [J]. MEDICAL DECISION MAKING, 2021, 41 (04) : E49 - E51
  • [5] A Retrospective Analysis From Patients Treated in The MEDALIST Study: Safety and Efficacy Of Luspatercept Treatment In Patients With Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts And Thrombocytosis
    Komrokji, Rami S.
    Platzbecker, Uwe
    Fenaux, Pierre
    Garcia-Manero, Guillermo
    Mufti, Ghulam J.
    Santini, Valeria
    Diez-Campelo, Maria
    Finelli, Carlo
    Jurcic, Joseph G.
    Greenberg, Peter L.
    Sekeres, Mikkael A.
    Zeidan, Amer M.
    Dezern, Amy E.
    Savona, Michael R.
    Shetty, Jeevan K.
    Ito, Rodrigo
    Zhang, George
    Ha, Xianwei
    Sinsimer, Daniel
    Backstrom, Jay T.
    Verma, Amit
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 67 - 68
  • [6] Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes
    Caocci, Giovanni
    La Nasa, Giorgio
    Efficace, Fabio
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 69 - 80
  • [7] Assessment of Dose-Dependent Response to Luspatercept in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts in the Phase 3 MEDALIST Trial
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 11 - 12
  • [8] Erythropoiesis biomarkers in patients with lower-risk myelodysplastic syndromes treated with luspatercept in the MEDALIST trial
    Platzbecker, U.
    Zhu, Y.
    Ha, X.
    Risueno, A.
    Chan, E.
    Zhang, G.
    Dunshee, D. R.
    Acar, M.
    Shetty, J. K.
    Ito, R.
    MacBeth, K.
    Santini, V
    Garbowski, M. W.
    Fenaux, P.
    Schwickart, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 211 - 213
  • [9] Efficacy and Safety of Luspatercept Treatment in Patients With Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis: A Retrospective Analysis From the MEDALIST Study
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 7 - 8
  • [10] Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
    Stojkov, Igor
    Conrads-Frank, Annette
    Rochau, Ursula
    Arvandi, Marjan
    Koinig, Karin A.
    Schomaker, Michael
    Mittelman, Moshe
    Fenaux, Pierre
    Bowen, David
    Sanz, Guillermo F.
    Malcovati, Luca
    Langemeijer, Saskia
    Germing, Ulrich
    Madry, Krzysztof
    Guerci-Bresler, Agnes
    Culligan, Dominic J.
    Kotsianidis, Ioannis
    Sanhes, Laurence
    Mills, Juliet
    Puntscher, Sibylle
    Schmid, Daniela
    van Marrewijk, Corine
    Smith, Alexandra
    Efficace, Fabio
    de Witte, Theo
    Stauder, Reinhard
    Siebert, Uwe
    [J]. BLOOD ADVANCES, 2023, 7 (12) : 2772 - 2783
12345